Barclays gave Charles Schwab a high-five in the form of a price target bump from $84 to $89 after an earnings beat that ...

Qtron Investments turned heads with a wild 943.6% leap in Lam Research shares, acquiring over 21,000 more in Q4. Qtron now ...

Booking Holdings just got a slight reality check as Wedbush revised its FY2026 earnings estimate from $234.44 to $226.28 per ...

NextEra Energy’s recent stock performance turned heads by notching a 1.02% gain, beating the S&P 500’s modest 0.13% climb.

Shares of RTX ticked up 0.9% on Monday as investors embraced a wave of bullish analyst upgrades and dividend vibes. Multiple ...

Mariner LLC decided AT&T’s line was worth holding, bumping its stake by 175,391 shares to a call-worthy 4.75 million total.

Lafayette Investments shaved a modest 2.1% off its Progressive holdings, selling 1,930 shares worth around $22 million.

Zacks Investment Management shaved off 4% of its BlackRock holdings in Q4, though it remains the firm’s 13th largest position ...

Micron’s stock took an 11% dive this week, and no, it wasn't an April Fool’s joke. Despite announcing a dividend and teaming ...

Zacks Investment Management recently reduced its stake in TJX Companies by 2.6%, shedding 6,340 shares and bringing its total ...

Analysts are having a love-hate relationship with Prologis, handing it a collective "Moderate Buy" despite some internal ...

CVS Health got a Wall Street-style vitamin boost as Robert W. Baird upped its price target from $51 to $71, signaling ...